TardiMed Sciences LLC, 10% Owner at Timber Pharmaceuticals, Inc. (TMBR), sold 225,000 shares at $0.94 ($212K) on 2021-09-02, disclosed to the SEC on 2021-09-02.
Open-market sale of $212k TMBR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| TMBR | SELL | 2021-08-26 | $276K | — | Filing → |
| TMBR | SELL | 2021-08-20 | $168K | — | Filing → |
| TMBR | SELL | 2021-06-15 | $408K | — | Filing → |